Unilife: Griffin Initiates at Buy, US$3 Target

Wednesday, 19 August 2009 03:00

The BioMedReports.com stock research section has been updated today with a research report for Unilife Medical Solutions (UNI.AX) (UNIFF.PK) written by Keith A. Markey, PhD, of Griffin Securities on 8/19/09 with a buy rating and $3 (U.S. Dollar) price target in addition to the most recent corporate presentation for the Company from 8/13/09. Click here for a link to coverage of Unilife at BioMedReports.com, which was initiated in late March 2009.

Highlights from the report include the following:

1.) Unilife has a disruptive drug delivery technology with a sound strategy to enter the U.S. and European needle and syringe markets

2.) Unilife has a big pharma partner in Sanofi-Aventis (NYSE:SNY), which is investing $38 million into the Company through an industrialization agreement

3.) Starting next year, additional supply agreements in other therapeutic areas (outside of the SNY agreement) are anticipated

4.) Unilife expects to obtain a U.S. listing for its stock, since it has relocated its headquarters to Pennsylvania and also has a major manufacturing facility there

Disclosure: No positions

BiomedReports is not paid or compensated to report news and developments about publicly traded companies. Full disclosure can be read at the bottom of / About Us / Section

Add this page to your favorite Social Bookmarking websites